What Is the Future of Monoclonal Antibody Therapy in Cancer Treatment?
The future of monoclonal antibody therapy in cancer treatment is promising. Ongoing research is focused on improving their efficacy and expanding their use across different cancer types. New developments include engineered antibodies that can engage the immune system more robustly, such as immune checkpoint inhibitors, and the use of monoclonal antibodies in combination therapies to enhance treatment outcomes. As our understanding of the molecular mechanisms of cancer improves, monoclonal antibodies will likely become an increasingly integral part of cancer care.
